135 related articles for article (PubMed ID: 3702600)
1. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
[TBL] [Abstract][Full Text] [Related]
2. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
3. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced dopamine hyposensitivity.
Goetz CG; Carvey PM; Tanner CM; Klawans HL
Life Sci; 1984 Apr; 34(15):1475-9. PubMed ID: 6538629
[TBL] [Abstract][Full Text] [Related]
5. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
Smith RC; Davis JM
Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
[No Abstract] [Full Text] [Related]
6. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
7. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
Costall B; Naylor RJ
Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
[TBL] [Abstract][Full Text] [Related]
8. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
Vetulani J
Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
[No Abstract] [Full Text] [Related]
9. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
Carvey PM; Kao LC; Zhang TJ; Amdur RL; Lin DH; Singh R; Klawans HL
Pharmacol Biochem Behav; 1990 Feb; 35(2):291-300. PubMed ID: 2320636
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.
Halperin R; Guerin JJ; Davis KL
Life Sci; 1983 Aug; 33(6):585-92. PubMed ID: 6684202
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
Lai H; Carino MA; Horita A
Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
Kenny M; Leonard BE
J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
Gattaz WF; Emrich A; Behrens S
J Neural Transm Gen Sect; 1993; 92(2-3):197-201. PubMed ID: 8369109
[TBL] [Abstract][Full Text] [Related]
14. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
Smith RC; Davis JM
Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
[TBL] [Abstract][Full Text] [Related]
15. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
[TBL] [Abstract][Full Text] [Related]
16. The effects of haloperidol and thioridazine on apomorphine- and LSD-induced hyperthermia in the rabbit.
Roszell DK; Horita A
J Psychiatr Res; 1975 Aug; 12(2):117-23. PubMed ID: 1171973
[No Abstract] [Full Text] [Related]
17. Diltiazem or verapamil prevents haloperidol-induced apomorphine supersensitivity in mice.
Grebb JA; Shelton RC; Freed WJ
J Neural Transm; 1987; 68(3-4):241-55. PubMed ID: 3559539
[TBL] [Abstract][Full Text] [Related]
18. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
19. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
Butkerait P; Friedman E
Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
Tschanz JT; Rebec GV
Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
